Immunotherapy
916 articles
Electricity-Based Treatment Boosts Overall Survival
Dr. Vincent Picozzi is enthusiastic about the results of the PANOVA-3 trial, which uses an electricity-based technique to kill cancer cells.
mRNA Vaccine Trial Expands to Numerous Locations
The mRNA vaccine trial spearheaded by Dr. Vinod Balachandran has opened in more locations in the US and around the world.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
NALIRIFOX Shows Promise in Early Studies
Dr. Zev Wainberg describes the new combination NALIRIFOX, being tested in the NAPOLI-3 clinical trial for advanced pancreatic cancer patients.
The Positive Impact of a Pancreatic Cancer Clinical Trial
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.
Research Highlights from ASCO GI 2026
The latest research on drugs targeting KRAS and new immuotherapy combinations were among the highlights of ASCO GI 2026.
Leaning into the Fight: My Battle with Pancreatic Cancer
Despite an extensive family history of pancreatic cancer, Deanna Burney’s doctors did not keep a close eye on her pancreatic cyst.
Far More Time than I Originally Expected
After a Whipple procedure, SBRT, and chemotherapy, Robert Glazier is staying informed about treatment options for pancreatic cancer.
The Body and the Brain
When her husband Ryan was diagnosed with pancreatic cancer at age 36, Brooke Dwars decided it was time to take charge.
Ready to Fight
Russell Reed lost his father-in-law to pancreatic cancer so he knew how important the right doctor would be for his own treatment.
Pancreatic Cancer, Diabetes, and Endocrine Health: What You Need to Know
If you are dealing with diabetes and pancreatic cancer, Dr. Afreen Shariff outlines why careful management is so important.
Extensive Family History and Genetic Testing Leads to Early Detection
Sidney Levinson and his doctor were aware of his BRCA1/2 mutations so when an MRI was recommended for screening, Sidney did it.
Sometimes Things Get Worse Before They Get Better
Matthew Rosenblum thought his time was limited after a pancreatic cancer diagnosis at age 32, but he’s a BRCA2 carrier, which opened treatment options.
Pancreatic Cancer Research Builds Upon Strengths
The September 2023 AACR Special Conference on Pancreatic Cancer focused on the latest research in KRAS, chemotherapy, and cachexia, among other topics.